The preventive immunization Nous-209 works in an initial trial with patients who have 17 times the risk of developing tumors ...

Viral vectors dominate gene therapy, with lentivirus, adenovirus, and AAV being key players, each with unique advantages and limitations. Non-viral vectors, such as lipid nanoparticles and GalNAc, ...

With winter flu cases rising in the UK, many are beginning to worry about mutations or variants that could pose a higher risk or greater resilience to vaccination. Cases of the H3N2 ‘superflu’ ...

Add Yahoo as a preferred source to see more of our stories on Google. Adenovirus isn’t as well-known as flu or COVID, but it’s one of the most common viruses people catch — especially in childhood. In ...

Adenovirus isn’t as well-known as flu or COVID, but it’s one of the most common viruses people catch — especially in childhood. In fact, most people will have been infected at least once before the ...